Since TRPV1 has been found to be sensitized by different mediators [20,48,49,50,51], we wanted to investigate if cytokines and neurotrophins associated with AD and inflammation can modulate TRPV1 surface expression on human eosinophils. Here, BDNF is linked to Alzheimer disease.